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A Ab bs st tr ra ac ct t
The correction of exogenous and endogenous environmental insult to DNA involves a series of DNA repair
mechanisms that reduce the likelihood of mutation accumulation and hence an increased probability of tumour
development. The mechanisms underlying the process of base excision repair are relatively well understood
and are placed in context with how deterioration of this process is associated with an increased risk of malignancy. 
B Ba as se e   e ex xc ci is si io on n   r re ep pa ai ir r
Base excision repair (BER) is one of the most
important DNA repair pathways, which ameliorates
environmentally induced DNA damage, including that
which arises spontaneously as a result of alkylation,
oxidation, and deamination events during normal
metabolic processes [1]. BER is also responsible for
repairing small, non-helix distorting lesions that may
be induced by chemical carcinogens [2]. In addition,
it is also responsible for the repair of abasic sites, which
may arise spontaneously as a function of temperature
fluctuation, or it could arise as intermediates in the
DNA repair process [3]. Compared with other repair
machinery, such as nucleotide excision repair, the core
components of BER machinery have been well
conserved from bacteria to humans both structurally
and functionally during evolution [4-7], underscoring
the vital role BER plays in maintaining genome integrity.
BER is believed to be the simplest and most defined of
all DNA repair processes. The molecular mechanism
of BER has been resolved to the tertiary structure for
all core components [8-10].
The BER pathway functions by a series of well-
coordinated enzymatic events which can overall be
divided into two steps. The first step of BER is the
recognition and excision of a damaged base or an abasic
site by a series of specific DNA glycosylases. The next step
involves the sequential action of different proteins which
correct DNA by template-directed insertion of one or 
a few nucleotides, starting at the damaged site.
The first step of BER relies on glycosylases that
recognize and remove the damaged base through 
N-glycosylic bond hydrolysis to generate abasic or
apurinic/apyrimidinic (AP) sites. These AP sites are
identical to spontaneous DNA depurination or
depyrimidation. Each of the glycosylases has specificity
to a relatively narrow, partially overlapping spectrum of
lesions, and may function as a monofunctional enzyme
(exclusively removes damaged base) or a bifunctional
enzyme (removes damaged base and incises DNA
backbone) [11]. Bifunctional glycosylases possess 
AP-lyase activity that hydrolyses the 3’-phosphodiester
bond of the AP site by a β- or β-δ-elimination
mechanism generating 3’ α,β-unsaturated aldehyde and 
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T Ta ab bl le e   1 1. .   DNA glycosylases involved in BER in human (modified from refs. [12, 18])
N Na am me e L Ly ya as se e    C Ch hr ro om mo os so om me e C Ce el ll lu ul la ar r K Kn no ow wn n   s su ub bs st tr ra at te es s R Re ef fe er re en nc ce es s
a ac ct ti iv vi it ty y l lo oc ca at ti io on n l lo oc ca al li iz za at ti io on n
MBD4 No 3q21-22 Nuclei G:T mismatches within methylated [19-22]
(also called MED1)  and unmethylated CpG sites. Can also remove 
uracil or 5-fluorouracil in G:U mismatches
MPG (also called  No 16p13.3 Nuclei 3-methyladenine, 7-methyl-guanine, [23-26]
AAG, ANPG, or MID1) hypo-xanthine, ethenoA
SMUG1 No 12q13.3 Nuclei Uracil (U) in single or double strand DNA,  [27, 28]
with a preference for single strand DNA
TDG No 12q24.1 Nuclei G/T, C/T, and T/T mispairs. Also uracil  [29-31]
and 5-bromouracil mispairs with guanine
UDG2 No 5 Nuclei U:A mismatch [32, 33]
UNG1 (also called DGU,  No 12q24.1 Mitochondria Uracil from misincorporation of dUMP residues [34-36]
UNG15, UDG1  by DNA polymerase or due to deamination 
or UDG1M) of cytosine
UNG2 (also called  No 12q24.1 Nuclei Uracil from misincorporation of dUMP residues [35, 36]
UDG1A or UDG1N) by DNA polymerase or due to deamination
of cytosine
MUTYH Yes (weak) 1p32.1-34.3 Nuclei and  A:8-oxoG and 2-OH-A:G [37, 38]
(also called MYH) mitochondria
NEIL1 (also called  Yes 15q22-24 Nuclei Oxidized pyrimidines, such as thymine glycol, [39, 40]
NEH1or FPG1) formamidopyrimidine (Fapy) and 5-hydroxyuracil. 
Also has a marginal activity towards 8-oxoguanine
NTH1 (also called  Yes 16p13.2-13.13 Nuclei and Damaged DNA at cytosines, thymines  [41, 42]
NTHL1 or OCTS3) mitochondria and guanines
OGG1 (also called MMH,  Yes 3p26.2 Nuclei and  8-oxoG:C, 7,8-dihydro-8-oxoguanine  [43, 44]
MUTM, or OGH1) mitochondria and 2,6-diamino-4-hydroxy-5-N-methylforma-
midopyrimidine (FAPY)
is then cleaved by a pivotal enzyme APE1 (also called
HAP1 or Ref) which has lyase and phosphodiesterase
activities [13]. Monofunctional DNA glycosylases need
the assistance of APE1 to hydrolyse the phosphodiester
bond at the 5’ end of the AP site via its lyase activity,
producing a single strand break (SSB) with a normal 
3’-hydroxyl group and an abnormal 5’-deoxyribose 
5-phosphate (dRP) residue [14].
Numerous prokaryotic and eukaryotic DNA
glycosylases have been isolated and purified. Their
substrate specificities have been determined using
various types of substrates. Moreover the crystal
structure of numerous DNA glycosylases has been
solved. Data obtained from structure determination
have allowed glycosylases to be grouped into several
major structural families by architectural folds [7],
including helix-hairpin-helix [15], helix-two-turn-
helix (H2TH) [16], and uracil DNA glycosylases
(UDGs) [17].
In humans about 11 mono-functional and
bifunctional glycosylases have been identified [12, 18]
(Table 1). The human mono-functional glycosylases
include methyl-CpG-binding domain protein 4 (MBD4),
N-methylpurine-DNA glycosylase (MPG), single-strand
selective mono-functional uracil DNA glycosylase
(SMUG1), thymine/uracil mismatch glycosylase (TDG),
uracil-DNA glycosylase 2 (UDG2), uracil DNA 
N-glycosylase (UNG1), and UNG2. The bifunctional
glycosylases include A/G-specific adenine DNA
glycosylase (MUTYH), endonuclease VIII-like 1 (NEIL1),
endonuclease III-like protein 1 (NTH1), and N-glyco-
sylase/DNA lyase (OGG1).
Determination of the crystal structure of glycosylases
has revealed that there exist differences in the folds and
specific residues used to recognize damaged bases. This
information, coupled by experimental characterization of
DNA base repair processes, has allowed enzymatic
mechanisms of cleavage by DNA glycosylases. Based on
specific mechanisms for recognition of damage, DNA
glycosylases can generally be grouped into those that
remove  oxidative damage, deamination products, and
alkylation damage. H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(4) 201
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As presented in Table 1, in human cells, the DNA
glycosylases that are involved in the removal of oxidized
bases include MUTYH, NEIL1, NTH1, OGG1, and
SMUG1. NEIL1, NTH1 and SMUG1 catalyze excision
of oxidized pyrimidines, such as 5-OHC, whereas
MUTYH and OGG1 repair oxidized purines, such as
8-oxoG. The human glycosylases that remove uracil
are uracil-DNA glycosylase (UNG/UDG), thymine-DNA
glycosylase (TDG), SMUG1, and MBD4. The only
glycosylase known to be involved in repair of alkylation
damage is MPG.
To complete repair after glycosylase action BER can
proceed through two different sub-pathways, short-patch
and long-patch pathway. These pathways are
differentiated by the enzymes involved and the number
of nucleotides removed. When BER is initiated by
bifunctional glycosylases, short patch is the main
pathway, whereas when BER is initiated by
monofunctional glycosylases it might proceed through
either pathway [45].
In the short-patch pathway, DNA polymerase 
β (Pol β), which is recruited upon direct interaction of
damaged DNA with APE1, extends the 3’-OH terminus
by inserting 1 nucleotide and at the same time removes
5’ terminal deoxyribose phosphate (5’-dRP) by its AP
lyase activity [46]. Finally, the single strand nick is
sealed by either DNA ligase I or DNA ligase III in 
a complex with the scaffolding protein XRCC1 [47, 48].
Long-patch BER is initiated in a manner similar 
to the short-patch pathway. Initially 2 to 12 nucleotides
are incorporated by a sequential action of three different
DNA polymerases (Pol β, δ, or ε) by elongating the 
3’ end by a few nucleotides and moving aside 
a DNA fragment which contains 5’ deoxyribophosphate
[49]. Next, this flap structure is cleaved out by specific
flap endonuclease, FEN1 [50, 51]. In addition to FEN1,
DNA synthesis and strand displacement is stimulated by
the combined presence of proliferating cell nuclear
antigen (PCNA) [52], replication factor C (RFC) [53], and
poly(ADP-ribose)polymerase 1 (PARP1) [54, 55]. Finally,
the intact DNA strand can be restored by DNA ligase I
or III. However, since this pathway is stimulated by PCNA,
it has been suggested that ligase I is the predominant
enzyme due to its interaction with PCNA [56].
M Mu ut tY Y   h ho om mo ol lo og gu ue e   ( (M MU UT TY YH H) )
S St tr ru uc ct tu ur re e  o of f  t th he e  M MU UT TY YH H g ge en ne e
The first human homologue of the E. coli MutY gene
was cloned by Slupska et al. [37]. By screening a human
cDNA sequence database they identified an expressed
sequence tag (EST) which was then used to probe 
a human bacterial artificial chromosome (BAC) library to
isolate genomic human mutY, which was referred to as
MUTYH, also called MYH. A full-length MUTYH cDNA
clone from a human brain tissue cDNA library was also
isolated which localized to the short arm of chromosome
1 between p32.1 and p34.3. MUTYH encompasses 7.1
kb and has 16 exons encoding a 535 amino acid protein
displaying 41% identity with E. coli protein [37]. Ohtsubo
and co-workers [38] identified 10 forms of MUTYH
transcripts, each with a different 5’ sequence or first exon
and each transcript being alternatively spliced, that were
sub-grouped into 3 types, isoform MUTYHα (splice
variants α1, 2, 3, and 4), isoform MUTYHβ (splice
variants β1, 3, and 5), and isoform MUTYHγ (splice
variants γ2, 3, and 4). The authors also showed that
MUTYH protein encoded by type α mRNA possesses 
a mitochondrial targeting sequence (MTS), consisting of
the amino terminal 14 residues which are required for its
localization in the mitochondria [57], while those encoded
by type β and γ mRNAs lack the MTS, and are localized
in the nuclei. MUTYHα3 is the major isoform expressed
in most cells and corresponds to the cDNA sequence
isolated and characterized by Slupska et al. [37]. In
addition to human, homologues of MutY have been
cloned from other mammals, including cow [58], mouse
[59] and rat [60].
T Th he e  p pr ro ot te ei in n  s st tr ru uc ct tu ur re e  a an nd d  f fu un nc ct ti io on n  o of f  M MU UT TY YH H
The open reading frame (ORF) of the full-length
major isoform of MUTYH (MUTYHα3) encodes a 535
amino acid protein [38]. This protein displays very high
identity with MutY homologues from other mammals,
78 and 74.1% identity with mouse and rat MutY,
respectively [61]. Structurally, MUTYH reveals extensive
homology and conservation with established structural
domains found in E. coli MutY and many prokaryotic
and eukaryotic BER enzymes, in addition to domains
unique to MUTYH (Fig. 1).
MutY and its homologues contain the catalytic 
domain which shares several motifs with other
glycosylases, including the helix-hairpin-helix (HhH),
pseudo-HhH and an [4Fe-4S] iron sulphur cluster in the
N terminus [62, 63]. The latter has a high overall similarity
to endonuclease III that excises oxidized pyrimidines [64,
65]. HhH (aa 114-273 in MUTYH) functions to detect,
recognize and remove adenines opposite to 8-oxoG 
by binding the phosphate backbone of the substrate. 
It includes a highly conserved aspartic acid residue
(Asp222 in MUTYH), which is required for nucleophilic
attack of the adenine base (reviewed in Ref. [61]). MutY
has a special carboxy-terminal domain that is not found
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homology to MutT (an 8-oxoGTPase), and this domain
has an important role in the recognition of 8-oxoG
because the truncation of the domain results in loss 
of discrimination between 8-oxoG:A and G:A mispairs
[66-68]. In addition, ORF of MUTYH also contains other
domains that are shown to be the binding sites of other
proteins. By using HeLa nuclear extracts, Parker and 
co-workers [69] demonstrated that MUTYH contains 
an APE1 binding site (aa 300), a replication protein 
A (RPA) binding site (aa 6-32), and a PCNA binding site
(aa 505-527).
The primary function of MUTYH as a BER DNA
glycosylase is to excise adenines or 2-hydroxy-adenines
(2-OH-A) misincorporated opposite 7,8-dihydro-8-
oxo-guanine (8-oxoG or GO) [70]. GO is one of the
most stable products of DNA damage resulting from
reactive oxygen species (ROS) [71] because this
oxidized form of the guanine base can pair with
adenine as well as cytosine with equal frequency during
DNA replication and thus has the potential to cause 
a high rate of G:C to T:A transversions [72, 73]. 
In  E. coli MutY, together with MutM and MutT
(formamidopyrimidine-DNA glycosylase: FPG), play
important roles in reducing the mutagenic effects of
GO lesions [74, 75]. MutM removes GO paired with
cytosine and introduces a single strand gap as a result
of the accompanying AP-lyase activity [75]; whereas
MutT hydrolyzes 8-oxo-dGTP and depletes it from the
nucleotide pool [73]. Similar DNA error avoiding
mechanisms have also been shown in human cells,
whereby MTH1 (MutT homologue), OGG1 (MutM
homologue), and MUTYH (MutY homologue) have
been proposed to function in the reduction of GO in
human genome [76].
Yang and co-workers demonstrated that the cloned
cDNA of MUTYH [37, 77] complement the mutator
phenotype of a MutY E. coli strain and prevented G:C
to T:A transversions [78]. Suppressive activities of
MUTYH against G:C to T:A transversions have also
been shown in human cells in vivo [79].
Unlike MTH1 or OGG1, MUTYH possesses no
detectable AP-lyase activity [78]. The authors also
demonstrated that APE1 catalytic activity is required
for the formation of cleaved AP DNA and stimulation
of  MUTYH glycosylase activity by increasing the
formation of the MUTYH-DNA complex. Similar
findings were also reported by Parker and co-workers,
who showed that MUTYH interacts with APE1, PCNA,
and RPA, suggesting a role in long-patch BER [69].
Despite the structural homology between MUTYH and
its bacterial counterpart, the human MUTYH protein
efficiently removes 2-OH-A from 2-OH-A:G
mismatches [38], while the bacterial protein removes
2-OH-A from the substrate containing 2-OH-A:G pairs
very poorly [80] (Fig. 2, 3).
Recent findings from experiments employing 
full-length structure of MutY cross-linked to DNA
containing 8-oxoG have shed light on the mechanism
of recognition and removal of 8-oxoG:A mismatched
by MutY. Although the precise mechanism is still
unclear, the results of these experiments suggest that
MutY relies heavily on the recognition of GO to locate
A bases for excision. For example, Fromme and 
co-workers [68] demonstrated that in the X-ray crystal
structure of an inactive variant (Asp144Asn) of 
B. stearothermophilus MutY there are extensive contacts
with 8-oxoG but minimal contacts with adenine. In
another instance Bernards and co-workers [82]
conducted time-resolved fluorescence experiments of
the MutY A-excision reaction using 8-oxoG•A
substrates and found a multiphase reaction profile,
with a fast process being associated with changes at
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8-oxoG and a slower process associated with altering
the environment of the adenine. MutY exposes its target
by deeply penetrating the DNA helix, interrupting
helical stacking on both strands, encircling the DNA
with its catalytic core and MutT-like domains, and
rotating the phosphodiester bonds surrounding the
nucleotide, causing the target base adenine to be
flipped out of the DNA helix [68, 83]. The iron-sulphurH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(4) 204
cluster [4Fe-4S] contained in the catalytic core of MutY
plays a significant role in facilitating DNA binding with the
damaged region and catalyzing the removal of adenine
[84]. This iron-sulphur cluster plays a DNA-dependent
electron transfer role which enables MutY to quickly and
efficiently seek out damaged sites in the genome using
DNA-mediated charge transport [85].
C Cr ro os ss s- -t ta al lk k  b be et tw we ee en n  M MU UT TY YH H a an nd d  o ot th he er r  D DN NA A  r re ep pa ai ir r  e en nz zy ym me es s
Evidence is accumulating in the literature
implicating the interactions of DNA glycosylases and
non-BER pathways, although in most cases the details
of the mechanism are not well understood [86]. In
addition to their participation in BER, DNA glycosylases
have been reported to interact with nucleotide excision
repair (NER) and mismatch repair (MMR).
MUTYH-initiated BER and MMR pathways share
common features in terms of function and timing of
action. Functionally, both pathways participate in
repairing DNA lesions resulting from DNA oxidation.
Both pathways take place immediately after DNA
replication to increase the fidelity of DNA replication
and bear a task to distinguish newly synthesized DNA
strands from their parental counterparts [37, 87-93].
The molecular evidence of the interaction of MUTYH
and MMR proteins was first obtained from an elegant
study by Gu and co-workers [94]. In their experiment they
found that hMUTYH directly interacts with hMSH6 in the
hMSH2/hMSH6 (hMutSα) heterodimer, which functions
to bind to the mismatches and initiate the repair on the
daughter DNA strands [95]. They also observed that this
physical protein interaction can occur in the absence of
DNA. Based on their findings, the authors further
hypothesized that proteins involved in DNA replication,
mismatch repair and base excision repair may exist as 
a multiple-protein complex and that hMUTYH may be
orientated in the replication fork to recognize 8-oxoG
on the parental strands and to excise misincorporated A
on the daughter strand [94]. This hypothesis is supported
by some evidence. Both hMUTYH and hMSH6 interact
with replication proteins PCNA and RPA [69, 96, 97].
Moreover, both proteins show overexpression during 
S phase and colocalize with PCNA at replication foci 
[69, 87, 96].
Although to date there is no direct evidence for the
physical interactions between MUTYH and proteins
involved in NER, there is evidence indicating that DNA
glycosylases are coupled to the NER pathway, more
specifically to the subpathway transcription-coupled
repair (TCR).
One example is the repair of thymine glycols which
are normally repaired by thymine glycol DNA glycosylase.
Leadon and Cooper [98] reported that thymine glycols
generated in NER- and BER-proficient human cells
following ionizing radiation exposure are removed in 
a biased fashion from the transcribed strand of an
expressed gene. In this case, TCR of thymine glycols exists
in the same locus in cells where BER is active, suggesting
that the thymine glycol-DNA glycosylase is coupled to
TCR. It is logical therefore that the question arises whether
such coupled repair exists for other lesions that are
normally repaired by BER glycosylases.
It has been proposed that the crucial event in
transcription-coupled NER (TC-NER) is the stalling of an
elongating RNA polymerase II upon a lesion, which
recruits the repair proteins to the damage site [99-102].
Therefore, the ability of a lesion on the transcribed strand
to block the RNA polymerase transcription complex 
has been assumed to be crucial for TCR. Kathe and 
co-workers [103] found that DNA base damage does
not block transcriptional elongation by RNA polymerase
II in HeLa cell nuclear extracts, but single-strand breaks
do. It is known that single-strand breaks are common
BER processing intermediates. It is therefore tempting to
speculate that a strand break produced by a DNA
glycosylase at an oxidative lesion in a transcription bubble
would serve as a block to the RNA polymerase apparatus
which in turn will signal the TC-NER to take place.
M MU UT TY YH H v va ar ri ia an nt ts s  a an nd d  t th he ei ir r  r ro ol le e  i in n  c ca ar rc ci in no og ge en ne es si is s
Cheadle and Sampson [104] have presented 
a comprehensive review of MUTYH variants and their
diagnostic implications. They reported that as of the end
of 2006, 30 mutations that are predicted to produce
truncated proteins have been reported in MUTYH,
consisting of 11 nonsense, 9 small insertion/deletions
and 10 splice site variants. Moreover, 52 missense
variants and three small inframe insertion/deletions have
been reported that are distributed throughout the gene
[104]. To date, as presented in Table 2, the list of
reported MUTYH variants has grown. Of the reported
variants, Y165C and G382D together account for
approximately 73% of reported MUTYH variants [104]
and have been commonly identified in Caucasian
populations, including American, British, Danish, Finnish,
Dutch, Italian, and Portuguese (reviewed in refs. [61,
105]). Beside these two variants, the occurrence of the
rest of the variants is rare, although recurrent variants
have been observed in some populations and will be
discussed later in this section.
As seen in Table 2, most of the variants reported, 
as is usually the case with most genes, are categorized
as single nucleotide polymorphisms (SNPs). SNPs 
are characterized by single base changes in genes and
other DNA sequences and are discovered by DNA 
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T Ta ab bl le e   2 2. .   List of reported MUTYH variants
T Ty yp pe e   o of f   m mu ut ta at ti io on n N Na am me e   o of f   m mu ut ta at ti io on n/ /v va ar ri ia an nt t R Re ef fe er re en nc ce es s
Nonsense R83X [106]
Y90X [107]
E182X [108]
Q196X
R233X
Q300X [108]
E466X [109]
Insertions/ 199delGT
deletions 252delG
263insAG
379delC
817delG
1059insC
1103-1105delC
1186-1187insGG
1419delC
Splice IVS1(36)+1G>A [110]
IVS1(36)+5G.C [111]
IVS4(347)-1G>C
IVS4(347)-1G>A
IVS5(421)-1G>C
IVS8(649)-1G>A
IVS10(891)+3A>C
IVS10(892)-2A>G [112]
IVS12(1145)-2A>G
IVS13(1281)+25del30 [108]
IVS15(1476)+2T>C
Missense M15V
and inframe  P18L [113]
ins/dels V22M [114]
G25D [113]
V61E [115]
D91N [116]
Y114H
W117R
137insIW
P143L
D147H
Y165C
Y166S
R168H
R168L
R68C
R171Q
G175E
I209V
V220M
R227W
R231C
R231H
V232F
R260Q
R260W
M269V
C276W
P281L
R295C
Q324H [114]
T Ta ab bl le e   2 2. .   List of reported MUTYH variants
T Ty yp pe e   o of f   m mu ut ta at ti io on n N Na am me e   o of f   m mu ut ta at ti io on n/ /v va ar ri ia an nt t R Re ef fe er re en nc ce es s
Q324R
F344Y
P345T
P366T [116]
L374P
G382D
P391S
P391L
Q400R
A405T
L406M
R412C
R423P [117]
R423Q [117]
R423R [117]
A459D
A459T
1391delAGG
1395delGGA (466delE)
V479F
Q484H
S501F [114]
P502L
re-sequencing, single strand conformation polymorphism
(SSCP), or nucleotide probing technologies, such as
pyrosequencing, real time PCR and multiplex ligation-
dependent probe amplification (MLPA). These single base
changes give rise to missense and nonsense variants and
may or may not result in an obvious phenotypic trait.
Over the past decade the determination of SNPs has
become an important method of characterizing the
individual differences in genetic makeup, as compared
to the “normal” genome sequence. Of potentially
greater importance are the SNPs that may increase an
individual’s susceptibility toward malignancy because of
subtle differences in the polymorphic protein products
due to nonsense mutations, especially when such
variations are present in key structural areas.
Evidence supporting a role for defective MUTYH in
human carcinogenesis is accumulating. The first study to
establish such a role was that of Al-Tassan and co-workers
[114], who described a British family in which three
siblings with colorectal cancer and adenomatous
polyposis were compound heterozygous for two germline
mutations in the MUTYH gene that result in MUTYH
proteins containing amino acid substitutions Tyr165Cys
(Y165C) and Gly382Asp (G382D). Unaffected family
members were either homozygous normal or hetero-
zygous for one of the mutations, thus suggesting an
autosomal recessive pattern of inheritance for the
phenotype of multiple adenomas. The authors further
showed that proteins containing these substitutions in 
E. coli lead to severe impairment of base excision repair.H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(4) 206
The Y165C mutation is located in the HhH motif, which
is highly conserved in all mammalian MutY as well as in
E. coli MutY proteins [62, 118, 119]. Functionally, it
completely abolishes adenine glycosylase activity toward
the A:8-oxoG mispair. The Gly382Asp mutation resides
in the MutT-like domain and also gives rise to decreased
adenine removal [114].
Since this discovery, which is the first to demonstrate
a direct link between a defective human DNA repair gene
and predisposition to colorectal cancer, considerable
work has established the relationship between mutations
in MUTYH and colorectal adenomas and carcinomas,
and this disorder is now referred to as MUTYH-associated
polyposis (MAP) [105, 107, 120]. To date, testing for
MUTYH variants is recommended for patients who have
clinical features of familial adenomatous polyposis (FAP)
but either do not have inherited mutations in APC or have
a family history consistent with recessive inheritance, as
is the case for MAP [121].
As seen in Table 2 there are many variants of MUTYH
reported in the literature, in addition to Y165C and
G382D. These variants range from simple one nucleotide
substitutions to insertions/deletions (indels) affecting more
than one nucleotide. Some of these variants may give rise
to non-functional MUTYH. Many of these variants,
however, are silent, causing missense changes, or are
small in-frame indels. Although without functional analyses
and/or segregation analyses it is problematic to
determine the effect of these variants, on the basis of
the type of mutation, the location in the sequence of
MUTYH, and the corresponding position in the structure
it of MUTYH, is possible however, to make a prediction
about the consequences of some of these types of
mutation in some cases.
Among examples of the variants in which the
consequence of MUTYH function may be predicted by
their corresponding position in the structure of MUTYH
are the P18L [113], V22M [114], and G25D [113]
variants. These three SNPs are present in the RPA binding
site in the N-terminus of MUTYH and could interfere with
the localization of MUTYH to the site of DNA replication.
In other instances, the variants E466X [109] and Y90X
[107], which were found in individuals of Indian and
Pakistani descent, respectively, represent truncated MUTYH
protein. In these variants, X indicates a stop codon which
results in premature termination of protein synthesis and
in turn gives rise to non-functional MUTYH protein.
Nonetheless, the consequences of most of the
missense variants are not obvious. Moreover, some
missense variants are not conserved in the bacterial
MutY enzymes, so it is difficult to make predictions
(reviewed in ref. [122]). This, coupled with their
collective frequency and lack of functional data, poses
major difficulties for molecular diagnostics since many
will be benign polymorphisms.
Mutations in the MUTYH gene and defective
MUTYH activities are just beginning to be identified in
human cancers. Consequently, it is obvious that more
information about the clinical and molecular properties
of MAP is needed to aid in the diagnosis and treatment
of affected patients and family members. Such
knowledge might also provide insight into how MUTYH
mutations contribute more globally to malignancies
other than colorectal cancer.
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